Tài liệu tham khảo |
Loại |
Chi tiết |
2. Đỗ Gia Tuyển (2007), “Suy thận mạn”, Bài giảng bệnh học nội khoa, tập 1, Trường Đại học Y Hà Nội, NXB Y học-Hà Nội, tr.428-445 |
Sách, tạp chí |
Tiêu đề: |
Suy thận mạn |
Tác giả: |
Đỗ Gia Tuyển |
Nhà XB: |
NXB Y học-Hà Nội |
Năm: |
2007 |
|
3. Bộ Y tế “Hướng dẫn chẩn đoán và điều trị một số bệnh về thận – tiết, ban hành kèm theo Quyết định số 3931/QĐ-BYT ngày 21/9/2015 của Bộ trưởng Bộ Y tế”Tiếng Anh |
Sách, tạp chí |
Tiêu đề: |
Hướng dẫn chẩn đoán và điều trị một số bệnh về thận – tiết, ban hành kèm theo Quyết định số 3931/QĐ-BYT ngày 21/9/2015 của Bộ trưởng Bộ Y tế |
|
9. N. Ridao, J. Lu˜no, S. Garc´ıa De Vinuesa, F. G´omez, A. Tejedor, and F.Valderr´abano, “Prevalence of hypertension in renal disease,” NephrologyDialysis Transplantation, vol.16,no. 1, pp.70–73, 2001 |
Sách, tạp chí |
Tiêu đề: |
Prevalence of hypertension in renal disease,” "NephrologyDialysis Transplantation |
|
14. Fliss E. M. Murtagh, Julia Addington Hall, Irene J.Higginson (2007), “The prevalence of symptoms in ERSD: a systematic review”, Advances in CKD-the journal of the national kidney foundation, Vol.14, Issue 1, p82-99 |
Sách, tạp chí |
Tiêu đề: |
The prevalence of symptoms in ERSD: a systematic review |
Tác giả: |
Fliss E. M. Murtagh, Julia Addington Hall, Irene J.Higginson |
Năm: |
2007 |
|
15. Murtagh F.E., Addington Hall JM, Edmonds DM, Donohol P, Carey I, Jenkins K, Higginson IJ (2007), “Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 CKD manage without dialysis”, The journal of palliative medicine, Vol.10, No.6, p.1266- 76 |
Sách, tạp chí |
Tiêu đề: |
Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 CKD manage without dialysis |
Tác giả: |
Murtagh F.E., Addington Hall JM, Edmonds DM, Donohol P, Carey I, Jenkins K, Higginson IJ |
Năm: |
2007 |
|
24. Rossing K, Jacobsen P, Pietraszek L, Parving HH "Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial." Diabetes Care 26 (2003):2268-74 |
Sách, tạp chí |
Tiêu đề: |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial |
Tác giả: |
Rossing K, Jacobsen P, Pietraszek L, Parving HH "Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial." Diabetes Care 26 |
Năm: |
2003 |
|
25. Wrenger E, Muller R, Moesenthin M, Welte T, Frolich JC, Neumann KH "Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases." BMJ 327 (2003): 147-9 |
Sách, tạp chí |
Tiêu đề: |
Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases |
Tác giả: |
Wrenger E, Muller R, Moesenthin M, Welte T, Frolich JC, Neumann KH "Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases." BMJ 327 |
Năm: |
2003 |
|
4. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010; 55:441– 51 |
Khác |
|
5. KDOQI Clinical Practice Guideline for Diabetes and CKD. Update. Am J Kidney Dis. 2012; 2012(60):850–86 |
Khác |
|
6. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008; 121:33240 |
Khác |
|
7. KDIGO Blood Pressure Group, KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease, Kidney International 2 (Suppl. 5) (2012) S337–S414 |
Khác |
|
8. Webster AC1, Nagler EV2, Morton RL3, Masson P4 Chronic Kidney Disease. Lancet. 2017 Mar 25; 389 (10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23 |
Khác |
|
11. Anuurad E., Shiwaku K., Nogi A., et al. (2003), "The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of |
Khác |
|
12. Kalyani B. Sonawane, BS; Jingjing Qian, PhD; and Richard A. Hansen, PhD (2014) Utilization Patterns of Antihypertensive Drugs Among the Chronic Kidney Disease Population in the United States: A Cross-Sectional Analysis of the National Health and Nutrition Examination Survey, pp 1 – 9 |
Khác |
|
13. Kalpana Bharani1*, Rajesh Bharani2, Rubina Vohra3, Chhaya Goyal1 (2003) Drug utilization pattern of antihypertensive drugs in chronic kidney disease stage 5 patients in a tertiary care hospital of central India |
Khác |
|
16. Alwyn P Saju, Ankur C Edakkarayil, Maheswari E, Gurudev KC (2016). Prescribing pattern and cost effectiveness analysis of antihypertensive drugs in chronic kidney disease patients, pp 219-225 |
Khác |
|
17. Daiyabu A Ibrahim, Aliyu Ibrahim, Hadiza Saidu (2017) Anti-hypertensive prescription pattern among general medical practitioners in Kano, Northern Nigeria, pp225-228 |
Khác |
|
18. Oluseyi Adejumo1, Enajite Okaka2, Ikponmwosa Iyawe (2017) Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria, pp 113 – 117 |
Khác |
|
19. Wollam, G. L., Tarazi, R. C., Bravo, E. L. & Dustan, H. P. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am. J. Med. 72, 929–938 (1982) |
Khác |
|
20. Pavitra RY, Geetha M, Aggarwal R and Somashekar HS: Drug utilization pattern of antihypertensive drugs in chronic kidney disease patients in a tertiary care hospital. IOSR Journal of Dental and Medical Sciences. 2014; 13(11): 23-27 |
Khác |
|